Cryptotanshinone ameliorates hepatic normothermic ischemia and reperfusion injury in rats by anti-mitochondrial apoptosis

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 11, 2014, Pages 1758-1765

  Sun, Ping Ping ^a   Yuan, Fang ^b   Xu, Jing ^c   Sai, Ke ^d   Chen, Jie ^a   Guan, Su ^e  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Apoptosis; Cryptotanshinone; Hepatic; Ischemia; Reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CRYPTOTANSHINONE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; BAX PROTEIN, RAT; PHENANTHRENE DERIVATIVE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; LIVER; LIVER INJURY; LIVER PROTECTION; MALE; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SALVIA MILTIORRHIZA; TREATMENT RESPONSE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM; MITOCHONDRION; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BCL-2-ASSOCIATED X PROTEIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; MALONDIALDEHYDE; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRENES; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 84910071840     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00389     Document Type: Article

References (45)

1. Olthoff KM. Can reperfusion injury of the liver be prevented? Trying to improve on a good thing. Pediatr. Transplant., 5, 390-393 (2001).
2. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J. Surg. Res., 147, 153-159 (2008).
3. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology, 51, 621-632 (2010).
4. Eguchi M, Miyazaki T, Masatsuji-Kato E, Tsuzuki T, Oribe T, Miwa N. Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamin C via hydrolytic conversion into ascorbate. Mol. Cell. Biochem., 252, 17-23 (2003).
5. Zhao J, Ming Y, Wan Q, Ye S, Xie S, Zhu Y, Wang Y, Zhong Z, Li L, Ye Q. Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities. Experimental and Therapeutic Medicine, 7, 1388-1392 (2014).
6. Duriez PJ, Shah GM. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol., 75, 337-349 (1997).
7. Plotnikov EY, Kazachenko AV, Vyssokikh MY, Vasileva AK, Tcvirkun DV, Isaev NK, Kirpatovsky VI, Zorov DB. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int., 72, 1493-1502 (2007).
8. Wang Y, Li B, Li Z, Huang S, Wang J, Sun R. Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochem. Res., 38, 742-752 (2013).
9. Jin YC, Kim CW, Kim YM, Nizamutdinova IT, Ha YM, Kim HJ, Seo HG, Son KH, Jeon SJ, Kang SS, Kim YS, Kam SC, Lee JH, Chang KC. Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur. J. Pharmacol., 614, 91-97 (2009).
10. Suh SJ, Jin UH, Choi HJ, Chang HW, Son JK, Lee SH, Jeon SJ, Son KH, Chang YC, Lee YC, Kim CH. Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-alphainduced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-kappaB and AP-1. Biochem. Pharmacol., 72, 1680-1689 (2006).
11. Wu L, Li X, Li Y, Wang L, Tang Y, Xue M. Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide. J. Ethnopharmacol., 126, 197-206 (2009).
12. Park OK, Choi JH, Park JH, Kim IH, Yan BC, Ahn JH, Kwon SH, Lee JC, Kim YS, Kim M, Kang IJ, Kim JD, Lee YL, Won MH. Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage. Fitoterapia, 83, 1666-1674 (2012).
13. Jin HJ, Xie XL, Ye JM, Li CG. TanshinoneIIA and cryptotanshinone protect against hypoxia-induced mitochondrial apoptosis in H9c2 cells. PLoS ONE, 8, e51720 (2013).
14. Jin Q, Jiang S, Wu YL, Bai T, Yang Y, Jin X, Lian LH, Nan JX. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D -galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 21, 141-147 (2014).
15. Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood, 93, 157-164 (1999).
16. Jiang H, Meng F, Li J, Sun X. Anti-apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats. World J. Surg., 29, 1397-1401 (2005).
17. Lim S, Jang HJ, Park EH, Kim JK, Kim JM, Kim EK, Yea K, Kim YH, Lee-Kwon W, Ryu SH, Suh PG. Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem., 113, 3436-3445 (2012).
18. Katori M, Buelow R, Ke B, Ma J, Coito AJ, Iyer S, Southard D, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation, 73, 287-292 (2002).
19. Lin HC, Liu SY, Lai HS, Lai IR. Isolated mitochondria infusion mitigates ischemia-reperfusion injury of the liver in rats. Shock, 39, 304-310 (2013).
20. Neuman MG. Apoptosis in diseases of the liver. Crit. Rev. Clin. Lab. Sci., 38, 109-166 (2001).
21. Cursio R, Filippa N, Miele C, Van Obberghen E, Gugenheim J. Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury. Br. J. Surg., 93, 752-761 (2006).
22. Kang KJ. Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transplant. Proc., 34, 2659-2661 (2002).
23. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol. Hepatol., 18, 891-902 (2003).
24. He SQ, Zhang YH, Venugopal SK, Dicus CW, Perez RV, Ramsamooj R, Nantz MH, Zern MA, Wu J. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transplantation : Oficial Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 12, 1869-1879 (2006).
25. Zhong Z, Lemasters JJ. Role of free radicals in failure of fatty liver grafts caused by ethanol. Alcohol, 34, 49-58 (2004).
26. Jin HJ, Li CG. Tanshinone IIA and Cryptotanshinone Prevent Mitochondrial Dysfunction in Hypoxia-Induced H9c2 Cells: Association to Mitochondrial ROS, Intracellular Nitric Oxide, and Calcium Levels. Evid. Based Complement. Alternat. Med., 2013, 610694 (2013).
27. Park EJ, Zhao YZ, Kim YC, Sohn DH. Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo. Food and Chemical Toxicology: an International Journal Published for the British Industrial Biological Research Association, 47, 2742-2748 (2009).\
28. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology, 30, 1223-1231 (1999).
29. Perry DK, Smyth MJ, Stennicke HR, Salvesen GS, Duriez P, Poirier GG, Hannun YA. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem., 272, 18530-18533 (1997).
30. Yao Y, Huang C, Li ZF, Wang AY, Liu LY, Zhao XG, Luo Y, Ni L, Zhang WG, Song TS. Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway. World Journal of Gastroenterology, 15, 1751-1758 (2009).
31. Jin S, Dai CL. Attenuation of reperfusion-induced hepatocyte apoptosis is associated with reversed bcl-2/bax ratio in hemi-hepatic artery-preserved portal occlusion. J. Surg. Res., 174, 298-304 (2012).
32. Nakagawa H, Maeda S. Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Pathol. Res. Int., 2012, 172894 (2012).
33. Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, Wagner EF, Cook SJ. Activation of ERK1/2 by deltaRaf-1:ER∗ represses Bim expression independently of the JNK or PI3K pathways. Oncogene, 22, 1281-1293 (2003).
34. Terada K, Kaziro Y, Satoh T. Analysis of Ras-dependent signals that prevent caspase-3 activation and apoptosis induced by cytokine deprivation in hematopoietic cells. Biochem. Biophys. Res. Commun., 267, 449-455 (2000).
35. Kakizaki S, Yamazaki Y, Takizawa D, Negishi M. New insights on the xenobiotic-sensing nuclear receptors in liver diseases - CAR and PXR. Curr. Drug Metab., 9, 614-621 (2008).
36. Grambihler A, Higuchi H, Bronk SF, Gores GJ. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J. Biol. Chem., 278, 26831-26837 (2003).
37. Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. Licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. J. Biol. Chem., 280, 10556-10563 (2005).
38. Park EJ, Zhao YZ, Kim YC, Sohn DH. PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation. Food and Chemical Toxicology: an International Journal Published for the British Industrial Biological Research Association, 45, 1891-1898 (2007).
39. Kelly-Laubscher RF, King JC, Hacking D, Somers S, Hastie S, Stewart T, Imamdin A, Maarman G, Pedretti S, Lecour S. Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. Cardiovasc. J. Afr., 25, 118-123 (2014).
40. Kim D, Hong J, Moon HH, Nam HY, Mok H, Jeong JH, Kim SW, Choi D, Kim SH. Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier. Journal of Controlled Release: Oficial Journal of the Controlled Release Society, 168, 125-134 (2013).
41. Vanezis A, Thaitirarot C, Butt M, Squire I, Samani N, Rodrigo G. 208 The PKC epsilon/AMPK ALPHA/ENOS pathway is implicated as a mechanism by which remote ischaemic conditioning attenuates endothelin-1 mediated cardiomyocyte hypertrophy. Heart, 100 (Suppl. 3), A114 (2014).
42. Lu L, Li C, Li D, Wang Y, Zhou C, Shao W, Peng J, You Y, Zhang X, Shen X. Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling. Mol. Cell. Biochem., 381, 273-282 (2013).
43. Jung JH, Kwon TR, Jeong SJ, Kim EO, Sohn EJ, Yun M, Kim SH. Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells. Evid. Based Complement. Alternat. Med., 2013, 805639 (2013).
44. Liu W, Yu B, Xu G, Xu WR, Loh ML, Tang LD, Qu CK. Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11). J. Med. Chem., 56, 7212-7221 (2013).
45. Park IJ, Yang WK, Nam SH, Hong J, Yang KR, Kim J, Kim SS, Choe W, Kang I, Ha J. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma. Apoptosis: an International Journal on Programmed Cell Death, 19, 615-628 (2014).